Riley de

Riley de León is a Producer for CNBC. He received his bachelor's degree in journalism from the University of Missouri, where he also studied business and strategic communications. His primary topics include technology, business, investing, and market news. Throughout his career at CNBC, Riley has reported on various companies such as Google-backed Tempus AI, Amazon, Meta-backed Scale AI, Taser and police body cam maker Axon's drone market entry and more. He is known for his timely coverage of the tech industry and financial markets.

Biography:  https://www.cnbc.com/riley-de-leon/

100%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

Tempus AI Goes Public: Raising $410.7M for Precision Medicine with a Market Valuation of $6B

Tempus AI Goes Public: Raising $410.7M for Precision Medicine with a Market Valuation of $6B

Broke On: Friday, 14 June 2024 Tempus AI, a company specializing in AI-powered medical diagnostics for precision medicine, went public on June 14, 2024. The IPO raised approximately $410.7 million and achieved a market valuation of around $6 billion. Founder and CEO Eric Lefkofsky holds 65% of the shareholder voting power post-IPO. Tempus AI's platform connects lab results to clinical data, serving over 7,000 physicians across hundreds of provider networks. The company offers genomics diagnostics tests in various areas such as neuropsychiatry, radiology, and cardiology.